Related Experiment Video
Updated: Jan 29, 2026
06:03
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
1.7K
Translational research in pulmonary fibrosis
Susan K Mathai1, David A Schwartz2
1Interstitial Lung Disease Program, Center for Advanced Heart & Lung Disease, Department of Medicine, Baylor University Medical Center at Dallas, Dallas, Texas; Department of Internal Medicine, Texas A&M University College of Medicine.
Translational Research : the Journal of Laboratory and Clinical Medicine
|February 16, 2019
Summary
Pulmonary fibrosis, a progressive lung disease, has genetic and genomic insights that are improving diagnosis and treatment. Understanding these factors is key to managing fibrotic interstitial lung disease and exploring new therapies.
Area of Science:
- Pulmonary medicine
- Genetics
- Genomics
Background:
- Pulmonary fibrosis causes lung abnormalities, leading to symptoms like dyspnea and hypoxemia.
- It is an irreversible and progressive condition, often necessitating lung transplantation.
- Etiologies include genetic defects, autoimmune diseases, and environmental exposures.
Purpose of the Study:
- To summarize recent advances in pulmonary fibrosis genetics and genomics.
- To discuss the impact of these discoveries on clinical diagnosis and treatment of fibrotic interstitial lung disease.
Main Methods:
- Literature review of recent research on pulmonary fibrosis genetics and genomics.
- Analysis of studies focusing on idiopathic pulmonary fibrosis.
Main Results:
- Recent discoveries are enhancing the understanding of genetic and genomic factors in pulmonary fibrosis.
- These advances are beginning to influence the clinical approach to patient care.
Conclusions:
- Genetics and genomics are crucial for understanding pulmonary fibrosis.
- New insights are paving the way for improved diagnostic and therapeutic strategies for fibrotic interstitial lung disease.
Related Concept Videos
01:31Translation
156.2K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.2K
01:31Translation
17.8K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.8K
02:33Initiation of Translation
38.9K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.9K
01:44Termination of Translation
27.7K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.7K
01:44Termination of Translation
6.8K
6.8K
02:07Improving Translational Accuracy
14.9K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.9K